Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): A multicentre, randomised, open-label trial

The Lancet Infectious Diseases

Volumn 12, Issue 12, 2012, Pages 933-941

  Puthanakit, Thanyawee ^a,b   Saphonn, Vonthanak ^d   Ananworanich, Jintanat ^a,b,c,q   Kosalaraksa, Pope ^e   Hansudewechakul, Rawiwan ^f   Vibol, Ung ^g   Kerr, Stephen J ^a,q   Kanjanavanit, Suparat ^h   Ngampiyaskul, Chaiwat ⁱ   Wongsawat, Jurai ^j   Luesomboon, Wicharn ^k   Ngo Giang Huong, Nicole ^l   Chettra, Kea ^d   Cheunyam, Theshinee ^a   Suwarnlerk, Tulathip ^a   Ubolyam, Sasiwimol ^a   Shearer, William T ^m   Paul, Robert ⁿ   Mofenson, Lynne M ^o   Fox, Lawrence ^p   Law, Matthew G ^q   Cooper, David A ^q   Phanuphak, Praphan ^a,b,c   Vun, Mean Chhi ^c   Ruxrungtham, Kiat ^a,b,c   more..

^a THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^b THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d National Center for HIV/AIDS Dermatology and STDs   (Cambodia)

^e KHON KAEN UNIVERSITY   (Thailand)

^f CHIANGRAI PRACHANUKROH HOSPITAL   (Thailand)

^g National Pediatric Hospital   (Cambodia)

^h NAKORNPING HOSPITAL   (Thailand)

ⁱ PRAPOKKLAO HOSPITAL   (Thailand)

^j Bamrasnaradura Infectious Diseases Institute   (Thailand)

^k Queen Savang Vadhana Memorial Hospital   (Thailand)

^l Institut de Recherchepour le Developpement IRD U174   (Thailand)

^m BAYLOR COLLEGE OF MEDICINE   (United States)

ⁿ UNIVERSITY OF MISSOURI ST LOUIS   (United States)

^o EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^p NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^q UNIVERSITY OF NEW SOUTH WALES   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL THERAPY; ARTICLE; CAMBODIA; CD4+ T LYMPHOCYTE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SURVIVAL RATE; THAILAND; TREATMENT OUTCOME;

ANTI-HIV AGENTS; CAMBODIA; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HIV; HIV INFECTIONS; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; MALE; THAILAND;

EID: 84869865451     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(12)70242-6     Document Type: Article

References (30)

1. UNAIDS report on the global AIDS epidemic 2010 UNAIDS, (accessed June 22, 2012). http://www.unaids.org/globalreport/Global_report.htm.
2. Ciaranello AL, Park JE, Ramirez-Avila L, Freedberg KA, Walensky RP, Leroy V Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions. BMC Med 2011, 9:59.
3. Ciaranello AL, Chang Y, Margulis AV, et al. Effectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis. Clin Infect Dis 2009, 49:1915-1927.
4. Blanche S, Newell ML, Mayaux MJ, et al. Morbidity and mortality in European children vertically infected by HIV-1. The French Pediatric HIV Infection Study Group and European Collaborative Study. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 14:442-450.
5. Chearskul S, Chotpitayasunondh T, Simonds RJ, et al. Survival, disease manifestations, and early predictors of disease progression among children with perinatal human immunodeficiency virus infection in Thailand. Pediatrics 2002, 110:e25. the Bangkok Collaborative Perinatal HIV Transmission Study Group.
6. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 2008, 359:2233-2244. the CHER Study Team.
7. Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach 2006, WHO, World Health Organization, Geneva.
8. Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach 2010, WHO, World Health Organization, Geneva.
9. de Martino M, Tovo PA, Balducci M, et al. Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. JAMA 2000, 284:190-197. the Italian Register for HIV Infection in Children and the Italian National AIDS Registry.
10. Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep 1994, 43:1-10. US Department of Health and Human Services.
11. Antiretroviral therapy of HIV infection in infants and children in resource-limited settings: towards universal access 2006, WHO, World Health Organization, Geneva.
12. NIH, DAIDS. Table for grading the severity of adult and pediatric adverse events. National Institute of Allergy and Infectious Diseases, Division of AIDS, 2004.
13. Notice on nelfinavir FDA-Pfizer letter, Sept 11, 2007 US Department of Health and Human Services Pediatric Panel, (accessed Aug 29, 2011). http://aidsinfo.nih.gov/contentfiles/PedNFVnotice1.pdf.
14. Chokephaibulkit K, Vanprapar N, Sutthent R, et al. Initiation of antiretroviral treatment with dual nucleoside reverse transcriptase inhibitors in human immunodeficiency virus-infected infants with less advanced disease in a resource-limited setting: a multi-center study in Thailand 1998-2000. J Med Assoc Thai 2005, 88(suppl 8):S1-S8.
15. Ruel TD, Zanoni BC, Ssewanyana I, et al. Sex differences in HIV RNA level and CD4 cell percentage during childhood. Clin Infect Dis 2011, 53:592-599.
16. Lumbiganon P, Kariminia A, Aurpibul L, et al. Survival of HIV-infected children: a cohort study from the Asia-Pacific region. J Acquir Immune Defic Syndr 2011, 56:365-371.
17. Collins IJ, Jourdain G, Hansudewechakul R, et al. Long-term survival of HIV-infected children receiving antiretroviral therapy in Thailand: a 5-year observational cohort study. Clin Infect Dis 2010, 51:1449-1457.
18. Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis. Lancet 2003, 362:1605-1611. HIV Paediatric Prognostic Markers Collaborative Study Group.
19. Gona P, Van Dyke RB, Williams PL, et al. Incidence of opportunistic and other infections in HIV-infected children in the HAART era. JAMA 2006, 296:292-300.
20. Severe P, Juste MA, Ambroise A, et al. Early versus standard antiretroviral therapy for HIV-infected adults in Haiti. N Engl J Med 2010, 363:257-265.
21. Taylor KM Relationship between visual motor integration skill and academic performance in kindergarten through third grade. Optom Vis Sci 1999, 76:159-163.
22. Sortor JM, Kulp MT Are the results of the Beery-Buktenica Developmental Test of Visual-Motor Integration and its subtests related to achievement test scores?. Optom Vis Sci 2003, 80:758-763.
23. Dunn M, Loxton H, Naidoo A Correlations of scores on the developmental test of visual-motor integration and copying test in a South African multi-ethnic preschool sample. Percept Mot Skills 2006, 103:951-958.
24. Ruel TD, Boivin MJ, Boal HE, et al. Neurocognitive and motor deficits in HIV-infected Ugandan children with high CD4 cell counts. Clin Infect Dis 2012, 54:1001-1009.
25. Puthanakit T, Aurpibul L, Louthrenoo O, et al. Poor cognitive functioning of school-aged children in Thailand with perinatally acquired HIV infection taking antiretroviral therapy. AIDS Patient Care STDS 2010, 24:141-146.
26. Laughton B, Cornell M, Grove D, et al. Early antiretroviral therapy improves neurodevelopmental outcomes in infants. AIDS 2012, 26:1685-1690.
27. Kekitiinwa A, Lee KJ, Walker AS, et al. Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland. J Acquir Immune Defic Syndr 2008, 49:384-392.
28. Puthanakit T, Kerr S, Ananworanich J, Bunupuradah T, Boonrak P, Sirisanthana V Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy. Pediatr Infect Dis J 2009, 28:488-492.
29. Kamya MR, Mayanja-Kizza H, Kambugu A, et al. Predictors of long-term viral failure among Ugandan children and adults treated with antiretroviral therapy. J Acquir Immune Defic Syndr 2007, 46:187-193. the Academic Alliance for AIDS Care and Prevention in Africa.
30. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach 2010 revision 2010, WHO, World Health Organization, Geneva.